Authors:
Lind, PARM
Wennberg, B
Gagliardi, G
Fornander, T
Citation: Parm. Lind et al., Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose, BREAST CANC, 68(3), 2001, pp. 199-210
Authors:
He, Q
Zou, L
Zhang, PA
Liu, JX
Skog, S
Fornander, T
Citation: Q. He et al., The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody, INT J B MAR, 15(2), 2000, pp. 139-146
Authors:
Nystedt, M
Berglund, G
Bolund, C
Brandberg, Y
Fornander, T
Rutqvist, LE
Citation: M. Nystedt et al., Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer - Self-rated physiological effects and symptoms, ACTA ONCOL, 39(8), 2000, pp. 959-968
Authors:
Billgren, AM
Rutqvist, LE
Tani, E
Wilking, N
Fornander, T
Skoog, L
Citation: Am. Billgren et al., Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival, ACTA ONCOL, 38(5), 1999, pp. 597-601
Authors:
Lind, PARM
Rosfors, S
Wennberg, B
Glas, U
Bevegard, S
Fornander, T
Citation: Parm. Lind et al., Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning, RADIOTH ONC, 49(3), 1998, pp. 245-254